189 related articles for article (PubMed ID: 17382108)
1. Follow-up study of a randomized controlled trial of postnatal dexamethasone therapy in very low birth weight infants: effects on pulmonary outcomes at age 8 to 11 years.
Nixon PA; Washburn LK; Schechter MS; O'Shea TM
J Pediatr; 2007 Apr; 150(4):345-50. PubMed ID: 17382108
[TBL] [Abstract][Full Text] [Related]
2. Effect of dexamethasone exposure on the neonatal unit on the school age lung function of children born very prematurely.
Harris C; Crichton S; Zivanovic S; Lunt A; Calvert S; Marlow N; Peacock JL; Greenough A
PLoS One; 2018; 13(7):e0200243. PubMed ID: 29985964
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary outcome in former preterm, very low birth weight children with bronchopulmonary dysplasia: a case-control follow-up at school age.
Vom Hove M; Prenzel F; Uhlig HH; Robel-Tillig E
J Pediatr; 2014 Jan; 164(1):40-45.e4. PubMed ID: 24055328
[TBL] [Abstract][Full Text] [Related]
4. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity.
Yeh TF; Lin YJ; Lin HC; Huang CC; Hsieh WS; Lin CH; Tsai CH
N Engl J Med; 2004 Mar; 350(13):1304-13. PubMed ID: 15044641
[TBL] [Abstract][Full Text] [Related]
5. Aerobic fitness and physical activity levels of children born prematurely following randomization to postnatal dexamethasone.
Nixon PA; Washburn LK; Mudd LM; Webb HH; O'Shea TM
J Pediatr; 2011 Jan; 158(1):65-70. PubMed ID: 20732688
[TBL] [Abstract][Full Text] [Related]
6. Vitamin A status and postnatal dexamethasone treatment in bronchopulmonary dysplasia.
Shenai JP; Mellen BG; Chytil F
Pediatrics; 2000 Sep; 106(3):547-53. PubMed ID: 10969101
[TBL] [Abstract][Full Text] [Related]
7. Respiratory outcome in school-aged, very-low-birth-weight children in the surfactant era.
Korhonen P; Laitinen J; Hyödynmaa E; Tammela O
Acta Paediatr; 2004 Mar; 93(3):316-21. PubMed ID: 15124832
[TBL] [Abstract][Full Text] [Related]
8. Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001145. PubMed ID: 29063594
[TBL] [Abstract][Full Text] [Related]
9. Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001146. PubMed ID: 29063585
[TBL] [Abstract][Full Text] [Related]
10. Lung Function of Adults Born at Very Low Birth Weight.
Yang J; Kingsford RA; Horwood J; Epton MJ; Swanney MP; Stanton J; Darlow BA
Pediatrics; 2020 Feb; 145(2):. PubMed ID: 31900317
[TBL] [Abstract][Full Text] [Related]
11. Respiratory health, lung function, and airway responsiveness in school-age survivors of very-low-birth-weight.
Schraeder BD; Czajka C; Kalman DD; McGeady SJ
Clin Pediatr (Phila); 1998 Apr; 37(4):237-45. PubMed ID: 9564573
[TBL] [Abstract][Full Text] [Related]
12. Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia.
McEvoy C; Bowling S; Williamson K; McGaw P; Durand M
Pediatr Pulmonol; 2004 Jul; 38(1):55-63. PubMed ID: 15170874
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial of moderately early low-dose dexamethasone therapy in very low birth weight infants: dynamic pulmonary mechanics, oxygenation, and ventilation.
Durand M; Mendoza ME; Tantivit P; Kugelman A; McEvoy C
Pediatrics; 2002 Feb; 109(2):262-8. PubMed ID: 11826205
[TBL] [Abstract][Full Text] [Related]
14. Association between clinical variables related to asthma in schoolchildren born with very low birth weight with and without bronchopulmonary dysplasia.
Gonçalves Eda S; Mezzacappa-Filho F; Severino SD; Ribeiro MÂ; Marson FA; Morcilo AM; Toro AA; Ribeiro JD
Rev Paul Pediatr; 2016 Sep; 34(3):271-80. PubMed ID: 26987782
[TBL] [Abstract][Full Text] [Related]
15. Early life intervention with glucocorticoids has negative effects on motor development and neuropsychological function in 14-17 year-old adolescents.
ter Wolbeek M; de Sonneville LM; de Vries WB; Kavelaars A; Veen S; Kornelisse RF; van Weissenbruch M; Baerts W; Liem KD; van Bel F; Heijnen CJ
Psychoneuroendocrinology; 2013 Jul; 38(7):975-86. PubMed ID: 23107421
[TBL] [Abstract][Full Text] [Related]
16. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
[TBL] [Abstract][Full Text] [Related]
17. Controlled trial of dexamethasone in neonatal chronic lung disease: an 8-year follow-up of cardiopulmonary function and growth.
Mieskonen S; Eronen M; Malmberg LP; Turpeinen M; Kari MA; Hallman M
Acta Paediatr; 2003 Aug; 92(8):896-904. PubMed ID: 12948063
[TBL] [Abstract][Full Text] [Related]
18. Neonatal Caffeine Treatment and Respiratory Function at 11 Years in Children under 1,251 g at Birth.
Doyle LW; Ranganathan S; Cheong JLY
Am J Respir Crit Care Med; 2017 Nov; 196(10):1318-1324. PubMed ID: 28707987
[TBL] [Abstract][Full Text] [Related]
19. Postnatal dexamethasone exposure and lung function in adolescents born very prematurely.
Harris C; Bisquera A; Zivanovic S; Lunt A; Calvert S; Marlow N; Peacock JL; Greenough A
PLoS One; 2020; 15(8):e0237080. PubMed ID: 32764779
[TBL] [Abstract][Full Text] [Related]
20. Randomized Trial of 42-Day Compared with 9-Day Courses of Dexamethasone for the Treatment of Evolving Bronchopulmonary Dysplasia in Extremely Preterm Infants.
Marr BL; Mettelman BB; Bode MM; Gross SJ
J Pediatr; 2019 Aug; 211():20-26.e1. PubMed ID: 31349916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
